T1	Concept 0 6	Longer
T2	Concept 7 20	working times
T3	Concept 32 36	HCWs
R1	has-property Arg1:T2 Arg2:T1	
T5	Concept 51 55	more
T6	Concept 56 60	time
R2	has-property Arg1:T6 Arg2:T5	
T7	Action 64 74;75 79	contacting with
R3	in-time Arg1:T7 Arg2:T6	
R4	subject Arg1:T7 Arg2:T3	
T4	Concept 80 89	confirmed
T8	Concept 93 102	suspected
T9	Concept 112 120	patients
T10	Concept 103 111	COVID-19
R5	in-context Arg1:T9 Arg2:T10	
T11	Concept 112 120	patients
R6	in-context Arg1:T11 Arg2:T10	
R7	has-property Arg1:T9 Arg2:T8	
R8	has-property Arg1:T11 Arg2:T4	
T12	Action 132 140	increase
T13	Concept 147 154	chances
A1	Uncertain T12
R9	subject Arg1:T12 Arg2:T7	
R10	target Arg1:T12 Arg2:T13	
T14	Action 164 172	infected
T15	Concept 178 186	COVID-19
R11	in-context Arg1:T13 Arg2:T14	
R12	target Arg1:T14 Arg2:T3	
R13	subject Arg1:T14 Arg2:T15	
R14	causes Arg1:T2 Arg2:T7	
T16	Concept 215 234	depressive symptoms
T17	Concept 244 250	family
R15	causes Arg1:T7 Arg2:T16	
R16	in-context Arg1:T16 Arg2:T17	
R17	in-context Arg1:T17 Arg2:T3	
T18	Concept 278 283	PARP1
T19	Concept 284 293	inhibitor
R18	is-a Arg1:T18 Arg2:T19	
T20	Concept 294 300	CVL218
T21	Action 301 311	discovered
R19	subject Arg1:T21 Arg2:T20	
R20	target Arg1:T21 Arg2:T18	
T22	Concept 319 354	in silico drug repurposing framewor
R21	in-context Arg1:T21 Arg2:T22	
T23	Action 399 408	treatment
T24	Concept 381 390	potential
T25	Concept 412 420	COVID-19
R22	target Arg1:T23 Arg2:T25	
R23	has-property Arg1:T18 Arg2:T24	
A2	Uncertain T24
R24	in-context Arg1:T24 Arg2:T23	
T26	Concept 432 437	23.5%
T27	Concept 442 447	21.1%
T28	Concept 448 455	preterm
T29	Concept 456 462	births
R25	has-property Arg1:T29 Arg2:T28	
T30	Concept 473 481	newborns
T31	Concept 489 496	mothers
R26	in-context Arg1:T29 Arg2:T30	
R27	in-context Arg1:T30 Arg2:T31	
T32	Concept 502 511	confirmed
T33	Concept 515 524	suspected
T34	Concept 525 533	COVID-19
T35	Concept 534 543	pneumonia
R30	in-context Arg1:T35 Arg2:T34	
R31	in-context Arg1:T31 Arg2:T35	
T36	Concept 489 496	mothers
R28	has-property Arg1:T35 Arg2:T33	
T37	Concept 534 543	pneumonia
R29	in-context Arg1:T37 Arg2:T34	
R32	has-property Arg1:T37 Arg2:T32	
R33	in-context Arg1:T36 Arg2:T37	
*	same-as T27 T29
T38	Concept 456 462	births
T39	Concept 448 455	preterm
R34	has-property Arg1:T38 Arg2:T39	
T40	Concept 473 481	newborns
R35	in-context Arg1:T38 Arg2:T40	
R36	in-context Arg1:T40 Arg2:T36	
*	same-as T26 T38
T42	Concept 672 684	blood groups
T43	Concept 705 716;717 722	association risks
T44	Action 685 694	displayed
T41	Concept 668 669	A
T45	Concept 669 670	B
T46	Concept 670 671	O
R37	is-a Arg1:T46 Arg2:T42	
R38	is-a Arg1:T45 Arg2:T42	
R39	is-a Arg1:T41 Arg2:T42	
R40	subject Arg1:T44 Arg2:T46	
R41	subject Arg1:T44 Arg2:T45	
R42	subject Arg1:T44 Arg2:T41	
T47	Concept 695 704	different
R43	has-property Arg1:T43 Arg2:T47	
T48	Action 731 740	infection
T49	Concept 746 756	SARS-CoV-2
R44	in-context Arg1:T43 Arg2:T48	
R45	subject Arg1:T48 Arg2:T49	
T50	Concept 770 778	COVID-19
R46	entails Arg1:T48 Arg2:T50	
R47	target Arg1:T44 Arg2:T43	
T51	Concept 783 795	transmission
T52	Concept 796 811	characteristics
R48	in-context Arg1:T52 Arg2:T51	
T53	Concept 815 823	COVID-19
R49	in-context Arg1:T52 Arg2:T53	
T54	Concept 837 844	similar
R50	has-property Arg1:T52 Arg2:T54	
T55	Concept 857 865	pandemic
T56	Concept 866 875	influenza
R51	in-context Arg1:T54 Arg2:T56	
R52	has-property Arg1:T56 Arg2:T55	
T57	Action 892 902	facilitate
A3	Emphasized T57
A4	Uncertain T57
T58	Action 918 924	spread
T59	Concept 911 917	global
R53	has-property Arg1:T58 Arg2:T59	
R54	subject Arg1:T58 Arg2:T53	
R55	target Arg1:T57 Arg2:T58	
R56	subject Arg1:T57 Arg2:T52	
